Background. D-amphetamine maintenance therapy shows promise as a treatment for people with cocaine addiction. Preclinical studies using Long Access (LgA) cocaine self-administration procedures suggest Damphetamine may act by preventing tolerance to cocaine's effects at the dopamine transporter (DAT). However, Intermittent Access (IntA) cocaine self-administration better reflects human patterns of use, is especially effective in promoting addiction-relevant behaviors, and instead of tolerance, produces psychomotor, incentive, and neural sensitization. We asked, therefore, how D-amphetamine maintenance during IntA influences cocaine use and cocaine's potency at the DAT.
INTRODUCTION
Several pharmacological approaches are presently under study for treating cocaine addiction, but none is approved by North American, European or other agencies (1) (2) (3) . One promising strategy is to substitute cocaine with another dopaminergic agent (4) , such as D-amphetamine, but in a slower and longer-acting formulation that would be potentially less harmful. Low-dose D-amphetamine effectively decreases cocaine use in humans (5) (6) (7) (8) , non-human primates (9) (10) (11) (12) (13) and rats (14-17), with no or only transient effects on responding for food (9, 10, (12) (13) (14) . However, it is not entirely clear how D-amphetamine produces these effects, but they do not involve reduced brain cocaine concentrations, crosstolerance or increases in cocaine's anxiogenic, or other toxic effects (10, 14) . Cocaine blocks dopamine uptake at the dopamine transporter (DAT) to enhance dopamine transmission and produce reward (18), and therefore, D-amphetamine might interfere with cocaine's actions at the DAT, thereby attenuating addiction-relevant effects (19) (20) (21) (22) .
Indeed, Siciliano et al. (2018) reported that, in rats, continuous, low-dose D-amphetamine (5 mg/kg/day for 14 d via s.c. minipump) reduces cocaine selfadministration by preventing molecular changes that lead to a decrease (tolerance) in the ability of cocaine to inhibit dopamine uptake at the DAT in the nucleus accumbens core (NAcC) (23). However, Long-Access (LgA) cocaine self-administration procedures were used, which produce high and sustained brain cocaine concentrations (24-26). In humans, cocaine use is typically more intermittent, which would produce peaks and troughs in brain cocaine concentrations (19, 27) . In rats, Intermittent Access (IntA) cocaine self-administration results in much less cumulative cocaine intake than LgA, but in many respects is more effective in producing addiction-like behavior than LgA [(24-26, 28-33); Reviewed in (19, 20) ]. Of particular relevance here, LgA and IntA cocaine experience also produce opposite effects on the dopamine system: tolerance vs. sensitization, respectively, to cocaine-induced inhibition of dopamine uptake at the DAT and cocaine-induced dopamine overflow in the NAcC (33, 34). Our objective here, therefore, was to assess the effect of D-amphetamine treatment during IntA cocaine selfadministration on both addiction-relevant behaviors and cocaine's potency at the DAT.
METHODS AND MATERIALS
See Supplement for information on subjects, surgeries, self-administration training and statistical analyses.
Experiment 1: Effects of D-amphetamine Maintenance during Intermittent Cocaine Selfadministration on the Development of Psychomotor Sensitization and on Drug-Taking and -Seeking Behaviors
Intermittent-Access (IntA) sessions. Figure 1 (Exp-1) shows the sequence of experimental events. After self-administration training (1-h sessions), male Wistar rats were allocated to a 'COC + A' group and a 'COC' group. A minipump filled with D-amphetamine (5 mg/kg/day) was implanted subcutaneously in the COC + A rats (n = 11). COC rats received a saline-filled minipump (n = 11), or a sham surgery (n = 11). All rats then self-administered cocaine (0.25 mg/kg/injection, over 5 s) under a fixed ratio 3 schedule, for 14 IntA-sessions given on consecutive days. Each 5-h session consisted of ten, 5-min cocaine-available periods separated by 25min, no cocaine-available periods during which the levers were retracted (24). We measured cocaine intake and locomotion during IntA-sessions.
Responding under a progressive ratio (PR) schedule of cocaine reinforcement.
The day after the last IntA-session, minipumps were removed, and sham rats in the COC group that did not have minipumps received a second sham surgery. Two days later, incentive motivation for cocaine was assessed by quantifying responding for cocaine under a PR schedule [(35) , also see Supplement].
Extinction.
After testing under PR, all COC + A and half of the COC rats were given 10, 2-h extinction sessions (1 session/day), and then five, 2-h pre-reinstatement sessions to further decrease the influence of cocaine cues on subsequent reinstatement testing (36-38). During pre-reinstatement sessions, lever pressing no longer produced any exteroceptive cocaineassociated cues (also see Supplement).
Cocaine-induced reinstatement.
After extinction and pre-reinstatement sessions, the rats were tested for cocaine-induced reinstatement of drug-seeking behavior. This occurred ~3 weeks after the discontinuation of D-amphetamine treatment. Sessions were similar to pre-reinstatement sessions, except that immediately before each session, rats received cocaine i.p. (0, 7.5 or 15 mg/ml/kg, doses in ascending order, 1 dose/session, within-subjects design). Cocaine seeking was measured as the number of presses on the previously cocaineassociated lever (39, 40). To confirm that leverpressing behavior returned to baseline between tests, rats received an extinction session with no i.p. injection between reinstatement sessions.
Effects of D-amphetamine maintenance after a history of intermittent cocaine intake.
We also compared the response to cocaine before and after D-amphetamine treatment, using a withinsubjects design. We used half of the COC rats for this (11/22 COC rats; PR scores were similar in the two subsets of COC rats, see Figure S1 ). As Figure 1 (Exp-1) shows, after 14 IntA-sessions and testing under a PR schedule, D-amphetamine-containing minipumps (5 mg/kg/day) were implanted in 11 COC rats, and rats were given 14 additional IntA-sessions, now with concomitant D-amphetamine. The day after the last IntA-session, minipumps were removed. Two days later, the rats were tested under a PR schedule once again, as described above.
Experiment 2: Effects of D-amphetamine Maintenance during Intermittent Cocaine Selfadministration on Cocaine's Potency at the Dopamine Transporter
A new cohort of rats with D-amphetamine-containing minipumps (5 mg/kg/day) or sham-operated selfadministered cocaine (n = 13, including 7 Damphetamine-treated rats and 5 D-amphetaminenaive rats) or saline (n = 10, including 5 Damphetamine-treated rats) during 14 IntA-sessions (Figure 1; Exp-2 ). This yielded 4 groups; 'COC', 'COC + A', 'SAL', and 'SAL + A'. The day after the last session, minipumps were removed (sham rats were sham operated). Five days later, brain sections were prepared for FSCV, to measure cocaine-induced inhibition of dopamine uptake in the NAcC (see Supplement).
Figure 1. The sequence of experimental events. In experiment 1 (Exp-1), male Wistar rats self-administered cocaine under intermittentaccess (IntA) conditions (COC). Some rats received D-amphetamine maintenance (COC + A; 5 mg/kg/day, via s.c. osmotic minipump) during intermittent cocaine self-administration. We assessed cocaine intake, changes in locomotor activity during self-administration sessions, incentive motivation for cocaine [as measured by responding for the drug under a progressive ratio (PR) schedule of reinforcement], and cocaine-induced reinstatement of extinguished cocaine-seeking behavior. A subset of COC rats was also used to compare responding for cocaine under a PR schedule before and after D-amphetamine treatment, in a within-subjects design. In experiment 2 (Exp-2), male Wistar rats self-administered cocaine (COC) or saline (SAL), with or without concomitant D-amphetamine treatment (COC + A and SAL + A). Using fast-scan cyclic voltammetry (FSCV)
, we then assessed cocaine-induced dopamine reuptake inhibition at the dopamine transporter in the nucleus accumbens core. IntA, Intermittent Access. COC, Cocaine. A, D-amphetamine.
RESULTS

Experiment 1: Effects of D-amphetamine Maintenance during Intermittent Cocaine Selfadministration on the Development of Psychomotor Sensitization and on Drug-Taking and -Seeking Behaviors
Intermittent Access sessions.
Sham rats and rats with a saline minipump were similar on all behavioral measures, and therefore were pooled to form one group ('COC'). COC and COC + A rats self-administered a similar number of cocaine injections, and both groups also escalated their intake over time (Session effect, F13, 403 = 6.43, p < 0.0001; Figure 2A ). This confirms reports that IntA cocaine experience promotes escalation of intake [(26, 28, 31, 32, 41) , but see (24, 25)].
During the 1 st IntA-session, locomotion was similar in COC and COC + A rats, but it increased over time only in COC rats, and by the 14 th IntA-session, locomotion was greater in COC rats (Group x Session interaction effect, F13, 403 = 5.19, p < 0.0001; Group effect, F1, 31 = 4.51, p = 0.04; Bonferonni's tests, p = 0.005 at the 14 th IntA-session; Figure 2B ). Increased locomotion over sessions in COC rats could involve increased cocaine intake over sessions. This is unlikely because neither the degree of escalation nor cumulative cocaine intake predicted the increase in locomotion over sessions (r 2 = 0.01 and r 2 = 0.002, respectively; All P's > 0.05; data not shown). Thus, psychomotor sensitization developed to selfadministered cocaine [see also (25, 28, 42) ], and Damphetamine prevented this sensitization. D-amphetamine also produced qualitative changes in cocaine-induced locomotion. In COC rats, locomotion during IntA-sessions showed a spiking pattern (Figures 2C-E Figure 2F ; F29, 899 = 3.14, p < 0.0001, Figure 2G ; F29, 899 = 1.54, p = 0.04, Figure  2H . Group effect; F1, 31 = 9.79, p = 0.004; Figure 2H ; No other comparisons were significant). Thus, Damphetamine prevented psychomotor sensitization to cocaine and changed the temporal kinetics of cocaine-induced locomotion. 
), and D-amphetamine attenuated this (Figures 2C-E). This is highlighted in
IntA COC + A
Figure 2. D-amphetamine did not significantly influence cocaine intake, but it abolished both cocaine-induced psychomotor sensitization and spikes in locomotor activity during cocaine self-administration sessions. (A) Average number of cocaine injections per 5-min cocaine period (left Y-axis) and total number of cocaine injections per 5-h IntA-session (right Y-axis). (B) Locomotor activity/min increased over
Responding under a PR schedule.
D-amphetamine treatment was discontinued after the 14 th IntA-session. Two days later, rats received PR tests (Figure 3) . Both groups responded more for higher cocaine doses (Dose effect, F2, 62 = 34.11, p < 0.0001; Figure 3A) , and COC rats earned more cocaine than COC + A rats (Group effect, F1, 31 = 11.24, p = 0.002; Figure 3A ). This is further illustrated in Figures 3B-D, showing cumulative responding for cocaine during PR sessions. COC rats also persisted in responding for cocaine for longer than COC + A rats (Group effect on session duration, F1, 31 = 8.51, p = 0.007; data not shown). Thus, under a PR schedule, COC rats persevered in working for cocaine as cost in effort increased, to a greater extent than COC + A rats. This suggests that prior D-amphetamine maintenance reduced subsequent incentive motivation to obtain cocaine, perhaps by attenuating the incentive sensitization produced by IntA experience [present study and (24, 26, 30-32)].
In COC rats, cocaine intake during IntA-sessions did not predict responding for the drug under a PR schedule [0.063 mg/kg, r 2 = 0.03; Figure 3E ; 0.125 mg/kg, r 2 = 0.03; Figure 3F ; 0.25 mg/kg, r 2 = 0.13; Figure 3G ; All P's > 0.05; See also (25, 26, 43) ]. This extends the idea that cocaine consumption and appetitive responding for cocaine are dissociable (24, 26, 43-45). However, in COC + A rats, less cocaine intake during IntA-sessions predicted lower responding under a PR schedule (0.063 mg/kg, r 2 = 0.83; Figure 3E ; 0.125 mg/kg, r 2 = 0.71; Figure 3F ; 0.25 mg/kg, r 2 = 0.84; Figure 3G ; All P's ≤ 0.001). Thus, while D-amphetamine did not reduce cocaine intake during IntA-sessions (Figure 2A) , the amount of cocaine taken while D-amphetamine is onboard predicts later incentive motivation for cocaine. 
Figure 3. D-amphetamine maintenance during intermittent cocaine self-administration decreased subsequent responding for cocaine under a progressive ratio schedule of reinforcement. (A) Across cocaine doses, COC + A rats responded less for cocaine compared to COC rats. (B-D) Cumulative number of self-administered cocaine injections (left Y-axis) and corresponding ratio (right Yaxis) during each 5-h progressive ratio test, as a function of cocaine dose. (E-G) Correlations between the average number of cocaine injections taken per 5-min cocaine period over the 14
IntA-sessions and the ratio reached during progressive ratio tests at 0.063 mg/kg/infusion (E), 0.125 mg/kg/infusion (F) and 0.25 mg/kg/infusion (G) cocaine. Cocaine intake during IntA-sessions predicted responding for cocaine under a progressive ratio schedule in COC + A rats, but not in COC rats. *p = 0.002, Group effect. Data are mean ± SEM. n = 22 for the COC group, and n = 11 for the COC + A group. IntA, Intermittent Access. COC, Cocaine. A, D-amphetamine.
Extinction.
Both groups decreased responding over extinction sessions (Session effect, F9, 171 = 15.37, p < 0.0001; Figure 4A ), but COC rats responded more than COC + A rats (Session x Group effect, F9, 171 = 3.87, p = 0.0002; Group effect, F1, 19 = 10.41, p = 0.004; Figure  4A ), especially on the 1 st session (Bonferroni's tests, 1 st session; p < 0.0001. All other P's > 0.05; Figure   4A ). This suggests that COC rats attributed more incentive value to cocaine, to the cocaine-paired cues, or both. After extinction sessions, rats received 5 'pre-reinstatement' sessions, where active-lever presses no longer produced cocaine cues. Both groups decreased their active-lever pressing over sessions (Session effect, F4, 76 = 5.77, p = 0.0004; Figure 4B ), and there were no group differences. Priming injections of cocaine dose-dependently increased active-lever presses in both groups (Dose effect, F2, 38 = 19.26, p < 0.0001; Figure 4C ), but to a greater extent in COC than COC + A rats (Group x Cocaine dose effect, F2, 38 = 5.24, p = 0.01; Figure  4C ), after a 15 mg/kg cocaine prime (Bonferroni's tests, p = 0.003; all other P's > 0.05; Figure 4C ). Thus, D-amphetamine treatment during intermittent cocaine intake decreased later vulnerability to cocaine-induced relapse, long after the cessation of treatment.
Figure 4. D-amphetamine maintenance during intermittent cocaine self-administration decreased both later responding for cocaine under extinction conditions and cocaine-primed reinstatement of extinguished cocaine-seeking behavior. (A) Under extinction conditions, COC + A rats showed less cocaine-seeking behavior than COC rats, but both groups extinguished responding over time. (B) During pre-reinstatement sessions (additional extinction sessions, but where cocaine cues were no longer presented) both groups showed very low levels of cocaine-seeking behavior. (C) COC + A rats were less vulnerable to cocaine-induced reinstatement of
Effects of D-amphetamine Maintenance After a History of Intermittent Cocaine Intake.
After 14 IntA-sessions (Figure 2) and testing under a PR schedule (Figure 3) , 11 COC rats received 14 additional IntA-sessions (sessions 15-28), now with concomitant D-amphetamine. Damphetamine was then discontinued and responding for cocaine under a PR schedule was assessed again. Rats escalated their intake over the 28 IntAsessions (F27, 270 = 3.47, p < 0.0001; Bonferroni's test, IntA-session 1 versus 28, p = 0.02; Figure 5A ). Cocaine-induced locomotion increased over the first 14 IntA-sessions (i.e., without D-amphetamine treatment; Bonferroni's test; IntA-session 1 versus 14, p < 0.0001; Figure 5B ), and there was no further increment in locomotion over IntA-sessions 15 to 28, when rats were now on D-amphetamine (p = 0.66; Figure 5B ). This is further highlighted in Figures 5C-D showing that when locomotion is averaged over the 5-min cocaine periods, there is an increase between IntA-session 1 and 14 (t10 = 3.92, p = 0.003; Figure  5C ), but a decrease between IntA-session 15 and 28 (t10 = 2.37, p = 0.04; Figure 5D ). Before Damphetamine treatment, locomotion also followed a spiking pattern during IntA-sessions (Figures 5E-G) . D-amphetamine attenuated this spiking pattern (Figures 5H-J) . Thus, D-amphetamine attenuated psychomotor sensitization to cocaine. Before and after D-amphetamine treatment, rats responded more for higher cocaine doses under a PR schedule (Dose effect, F2, 20 = 79.03, p < 0.0001; Figure 6A ). Rats earned fewer cocaine injections after D-amphetamine treatment than before (Treatment effect, F1, 10 = 16.51, p = 0.002; Figure  6A , see also Figures 6B-D). After D-amphetamine treatment, cumulative cocaine intake during PR sessions was also decreased (Figures 6E-G) . Thus, although rats escalated their cocaine intake even further under D-amphetamine (IntA-sessions 15-28, see Figure 5A ), and they more than doubled their average cumulative cocaine exposure with these additional sessions (average cumulative cocaine intake; IntA-sessions 1-14; 183 mg/kg ± 41 SEM; IntA-sessions 1-28; 463 mg/kg ± 89 SEM), they showed less incentive motivation for cocaine after Damphetamine treatment. This suggests that while Damphetamine might not prevent escalation of cocaine intake, it decreases incentive motivation for cocaine. This is unlikely due to repeated testing, because with repeated testing, responding for cocaine under a PR schedule remains stable or even increases [(46), see also (30)].
Figure 5. D-amphetamine maintenance does not prevent the escalation of cocaine intake in already cocaine-experienced rats. (A) Average number of cocaine injections per 5-min cocaine period (left Y-axis) and total number of cocaine injections per 5-h IntA-session (right Y-axis). Before and with D-amphetamine treatment, rats escalated their cocaine intake over
Figure 6. In cocaine-experienced rats, D-amphetamine maintenance during intermittent cocaine self-administration decreases later responding for cocaine under a progressive ratio schedule of reinforcement. (A) Number of self-administered cocaine injections (left Y-axis) and corresponding ratio (right Y-axis) before and after D-amphetamine treatment. (B-D) Responding for cocaine under progressive ratio in individual rats before (b) and after (a) D-amphetamine treatment. (E-G) Cumulative number of self-administered cocaine injections (left Y-axis) and corresponding ratio (right Y-axis) during each 5-h progressive ratio test, as a function of cocaine dose.
Data are mean ± SEM. n = 11. *p = 0.002, Treatment effect. A, D-amphetamine.
Experiment 2: Effects of D-amphetamine Maintenance during Intermittent Cocaine Selfadministration on Cocaine's Potency at the Dopamine Transporter
COC and COC + A rats took similar amounts of cocaine, and D-amphetamine treatment increased saline self-administration ( Figure S2 ; unpaired ttests, COC vs. COC + A, t11 = 0.55, p = 0.59; SAL vs. SAL + A, t8 = 2.77, p = 0.02). As in experiment 1, locomotion followed a spiking pattern during cocaine self-administration sessions, increased across sessions (Figure 7A, black curves) , and Damphetamine blunted both effects. In rats selfadministering saline (Figure 7B) , D-amphetamine initially increased locomotion, but the SAL and SAL + A groups had similar locomotor counts by the last (14 th ) session. Five days after cessation of cocaine selfadministration/D-amphetamine treatment, we measured cocaine-induced inhibition of DA uptake in the NAcC using ex vivo FSCV. Figure 7C shows representative FSCV traces following bath-applied cocaine.
Increasing cocaine concentrations enhanced stimulated dopamine release, and this did not differ between groups (Percent of 0.3 μM cocaine, Concentration effect, F4, 72 = 36.97, p < 0.0001; Group effect, F3, 18 = 0.26, p = 0.85; Figure 7D ; Percent of SAL, Concentration effect, F4, 44 = 1.25, p = 0.3; Group effect, F1, 11 = 0.23, p = 0.64; Figure 7E ). As reported previously (33), 30 µM cocaine did not significantly alter stimulated dopamine release. Increasing cocaine concentrations also augmented dopamine uptake inhibition (Concentration effect, F4, 72 = 126.7, p < 0.0001; Figure 7F) , and the magnitude of this effect varied as a function of group (Group x Concentration effect, F12, 72 = 2.65, p = 0.005; Figure  7F ; F4, 44 = 3.56, p = 0.01; Figure 7G) . At 30 μM cocaine, dopamine uptake inhibition was greatest in COC rats (Bonferroni's tests; all P's < 0.05; Figures  7F-G) . Thus, IntA cocaine experience increased cocaine's potency at the DAT, as reported previously (29, 33). Importantly, D-amphetamine prevented this neurochemical sensitization. In cocaine-naive, SAL rats, D-amphetamine did not change cocaineinduced dopamine uptake inhibition [D-amphetamine effect, F1, 7 = 0.01, p = 0.1; D-amphetamine x Concentration effect, F4, 28 = 0.45, p = 0.77, Figure  7F ; See also (23, 47)]. Thus, D-amphetamine normalizes cocaine potency at the DAT by selectively reversing cocaine-induced neurochemical sensitization, without changing baseline DAT function.
DISCUSSION
Rats self-administered cocaine on an IntA schedule, with or without D-amphetamine maintenance treatment, and we assessed the development of addiction-like behavior (high motivation for cocaine and drug-induced relapse), psychomotor activity and cocaine-induced inhibition of DA uptake. We report three main findings. First, IntA cocaine self-administration induced psychomotor sensitization, which was attenuated by D-amphetamine treatment, despite no effect on cocaine consumption. Second, in both previously cocaine-naive rats and in cocaine-experienced rats, D-amphetamine treatment decreased incentive motivation for cocaine (measured using PR procedures), responding for cocaine under extinction and cocaine-primed relapse, relative to animals that received cocaine alone. Third, IntA enhanced cocaine's potency at the DAT, and D-amphetamine prevented this effect, without changing basal DAT function. Thus, D-amphetamine treatment during IntA cocaine self-administration may reduce motivation for cocaine by interacting with the DAT to prevent sensitization-related changes in cocaine potency and dopamine-mediated signalling.
Long Access versus Intermittent Access
D-amphetamine maintenance therapy can decrease cocaine use in people with addiction (5) (6) (7) (8) , and so the neurobiological and psychological basis of this effect is of interest. In an earlier study addressing this question Siciliano et al. (2018) trained rats to self-administer cocaine for 6 hrs/day (LgA) (23), and there is now a large literature showing that LgA is especially effective in producing addiction-like behaviors, relative to rats only allowed access for 1-2 hrs/day (Short Access, ShA). These behaviors include escalation of intake, high motivation for drug, a high propensity to relapse and continued drug-seeking in the face of an adverse consequence (24, 48-51). It is also reported that LgA experience produces tolerance in the ability of cocaine to inhibit the DAT (33, 52, 53). Importantly, Siciliano et al. (2018) found that D-amphetamine maintenance treatment not only prevented and reversed the escalation of cocaine intake and the increase in motivation for cocaine otherwise produced by LgA experience (23), but also prevented the tolerance to cocaine's effect on the DAT produced by LgA (23). They proposed, therefore, that D-amphetamine attenuated addictionlike behavior because it reversed the tolerance produced by extended cocaine use (23). This is consistent with the view that addiction results from tolerance-related adaptations in the DA system, whereby drug-seeking and drug-taking behavior is motivated primarily to overcome this 'DA deficiency' and associated anhedonia (54, 55).
However, recent studies using IntA selfadministration procedures have begun to paint a very different picture of how cocaine use changes brain and behavior to promote problematic patterns of use [(24-26, 28-33, 56); Reviewed in (19, 20)]. During LgA, brain cocaine concentrations are maintained at a steady high level for the duration of the selfadministration session, and the resultant large amount of cocaine consumption was thought to be necessary for the development of addiction-like behavior (48, 57, 58) . It turns out this is not the case. Zimmer et al (2011) initially developed the IntA cocaine-self-administration procedure (59) , which results in an intermittent, 'spiking' pattern in brain cocaine concentrations, because it was thought to better model patterns of cocaine use in humans (27, 60) . Importantly, despite much less total cocaine consumption than LgA (comparable to ShA conditions) IntA experience not only also produces escalation of cocaine intake, but is either more effective, or at least as effective, as LgA in producing the addiction-like behaviors described above [(24-26, 28, 30-32, 34); Reviewed in (19, 20)]. Furthermore, rather than producing tolerance, IntA experience enhances (sensitizes) cocaine's potency in inhibiting DA uptake ex vivo (29, 33), and cocaine-induced DA overflow in vivo (34). This is consistent with the behavioral and neurobiological effects of experimenter-administered cocaine when given continuously versus intermittently (61, 62) .
Given the dramatic differences in the effects of LgA vs. IntA on the DAT, it was important to determine the effects of D-amphetamine treatment on addiction-like behavior and DAT function in rats with IntA experience. D-amphetamine treatment attenuated addiction-like behavior produced by intermittent cocaine intake, as indicated by reductions in motivation for cocaine, responding during extinction and in the magnitude of cocaine-induced reinstatement of cocaine seeking. D-amphetamine was efficacious both in previously cocaine-naive rats and in cocaine-experienced rats, suggesting that Damphetamine can suppress both the development and the expression of addiction-like behavior. Damphetamine did not change cocaine's effects on electrically-evoked dopamine release or cocaine's potency at the DAT in cocaine-naive rats [See also (23, 47)], but, importantly, it prevented the sensitization of cocaine's action at the DAT produced by IntA. We hypothesize, therefore, that Damphetamine reduced the high motivation for cocaine produced by IntA experience by preventing sensitization to cocaine's effects at the DAT, without changing baseline DAT function. This is consistent with an incentive-sensitization view of addiction (63) .
How can both an increase and decrease in DAT function attenuate addiction-like behavior?
It is intriguing that D-amphetamine treatment reduces the development of addiction-like behavior produced by both LgA (23) and IntA cocaine selfadministration experience (present findings), but produces apparently opposite effects on DAT function under these two conditions. One possibility is that at least some of the addiction-like behaviors produced by LgA versus IntA experience are due to drug-induced changes in different neuropsychological processes (31). For example, the escalation of intake and the high level of effort expended to obtain cocaine could be because of tolerance to cocaine's desired effects in the case of LgA, but to sensitization of drug 'wanting' in the case of IntA (20, 31, 34). Two lines of evidence support this idea. First, IntA produces sensitization to the psychomotor activating, incentive motivational and dopamine-increasing effects of cocaine (24-26, 28, 29, 31, 33, 34, 42, 43, 56) , whereas LgA can decrease the psychomotor activating effects of cocaine and dopamine function, at least soon after the discontinuation of LgA (33, 52, 53, 64) . Note that psychomotor sensitization may be expressed after a long period of withdrawal from LgA (50, 56). Second, D-amphetamine treatment reduced the escalation of cocaine intake under LgA conditions (23), but not during IntA (present study), further suggesting that different processes are involved.
We were surprised that D-amphetamine reduced incentive motivation for cocaine, but on average it did not affect the escalation of cocaine intake during IntAsessions. This was surprising given that Damphetamine suppressed the development of psychomotor sensitization across IntA-sessions. This could indicate that escalation of cocaine intake during IntA experience does not necessarily reflect sensitization of an appetitive process, and that cocaine consumption and appetitive responding for the drug are dissociable (24, 26, (43) (44) (45) . Indeed, we found that cocaine intake during IntA-sessions did not predict responding for the drug under a PR schedule [see also (26, 28, 42) ]. Alternatively, perhaps Damphetamine's therapeutic effects are most robust after the cessation of treatment, because rats can take enough cocaine during IntA-sessions to overwhelm any effect of ongoing D-amphetamine treatment on the DAT. The implication is that Damphetamine maintenance reduces incentive motivation for cocaine by inoculating against cocaineinduced, sensitization-related plasticity at the DAT. Future work should also examine behavioral and neurochemical outcome at different timepoints after the discontinuation of continuous D-amphetamine, as the effects of continuous psychostimulant drug treatment can change following longer withdrawal periods (50, 56, 65).
IntA not only produces successive 'spikes' in brain cocaine levels (24, 59) but in psychomotor activity, as seen here. Typically, there is a strong correlation between brain concentrations of cocaine, extracellular concentrations of DA in the striatum, and the time course of the psychomotor activating effects of cocaine (66) (67) (68) . It is interesting, therefore, that Damphetamine 'flattened' the spikes in psychomotor activity otherwise produced by intermittent cocaine intake [see also (28) ]. We speculate that Damphetamine may have also attenuated the intermittent 'spikes' in DA that would otherwise occur with IntA self-administration. The importance of intermittency in producing sensitization-related changes in brain and behavior has been longrecognised (69) (70) (71) (72) (73) , and therefore, D-amphetamine may have therapeutic effects because it blunts the intermittent spikes in striatal dopamine activity that promote the induction of sensitization. This hypothesis remains to be tested.
CONCLUSIONS
Using a cocaine self-administration procedure that models intermittent cocaine taking in humans (24, 27, 59), we report that intermittent cocaine use produces robust sensitization to both the psychomotoractivating and DAT-inhibiting effects of cocaine. This extends reports that intermittent-access cocaine promotes sensitization to cocaine's dopamineelevating effects [(29, 33, 34) ; See (20) for review]. The original finding here is that D-amphetamine attenuates the cocaine-taking and -seeking behaviors otherwise promoted by intermittent cocaine intake, and that this is associated with blunting of sensitization-related changes in cocaine potency at the DAT. This is consistent with the view that the transition to cocaine addiction involves sensitizationrelated neuroplasticity (63) , and therefore, treatments that reverse this may be especially efficacious. caudal to the catheter. Rats allocated to the Damphetamine condition were implanted with a minipump filled with D-amphetamine. These are the COC + A rats in Experiment 1, and COC + A as well as SAL + A rats in Experiment 2. In Experiment 1, rats allocated to the COC group were implanted with a minipump filled with saline or received a sham surgery consisting of an incision and sutures. In Experiment 2, COC and SAL rats received a sham surgery.
Responding under a PR schedule
Obtaining each cocaine injection (0.063-0.25 mg/kg/injection, one session/dose, counterbalanced) required an exponentially increasing number of lever presses, according to the following formula: !5 × ('()*+, -. /'0+12/-' × 3.5) − 58 (35). Sessions ended after 5 hours or when 1 h elapsed without a selfadministered injection.
Extinction
For 10, 2-h sessions, rats were tethered to the infusion apparatus and had continuous lever access. Each three active-lever presses produced exteroceptive cocaine-associated cues (i.e., syringe pump activation, lever retraction and illumination of the cue light for 5 seconds), but no cocaine. The day following the last extinction session, rats received five, 2-h pre-reinstatement sessions to further decrease the influence of cocaine cues on subsequent reinstatement testing (36-38). During these sessions, the rats were placed in the operant cages but were not connected to the infusion apparatus. Cages were also unlit and lever presses had no consequences.
Effects of cocaine on dopamine uptake inhibition in the nucleus accumbens core (NAcC) ex vivo
We used a fast scan cyclic voltammetry (FSCV) protocol similar to that described in our previous work (81) (82) (83) . Rats were injected i.p. with sodium pentobarbital (90 mg/kg) and perfused with a NMDGbased solution (in mM; 92 NaCl, 2.5 KCl, 1.25 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 2 thiourea, 5 ascorbic acid, 3 sodium pyruvate, 2 CaCl2, 2 MgSO4) for at least 1 hour at room temperature. The brain was extracted, and 300-μm-thick coronal slices were prepared in ice-cold (0 to 4°C) NMDG solution using a vibrating blade microtome (Leica VT1000S). Slices were first placed in a 32°C NMDG solution for 12 min and then in an oxygenated HEPES-buffered resting solution (in mM; 92 NaCl, 2.5 KCl, 1.25 NaH2PO4, 30 NaHCO3, 20 HEPES, 25 glucose, 2 thiourea, 5 ascorbic acid, 3 sodium pyruvate, 2 CaCl2, 2 MgSO4) for at least 1 h at room temperature. A slice containing the NAcC [approximately +1.7 mm from Bregma (84) ] was placed in the recording chamber and continuously perfused (1 ml/min) with oxygenated aCSF (in mM; 119 NaCl, 2.5 KCl, 1.25 NaH2PO4, 24 NaHCO3, 12.5 glucose, 2.4 CaCl2, 1.3 MgSO4) at 32°C. A carbon-fiber electrode (CFE, ~7 μm in diameter) was placed ~100 μm below the surface of the slice, into the NAcC and centered between the two poles of the bipolar stimulating electrode (Plastics One, Roanoke, VA, US) placed on the slice surface. Single-pulse electrical stimulations (400 μA; 1 ms) were generated every 5 minutes to evoke dopamine release and the potential at the CFE was scanned according to a 10-ms triangular voltage wave (-0.4 to 1 to -0.4 V vs. Ag/AgCl, at the rate of 300 V/s). Dopamine release was analyzed as the peak height of electrically-evoked extracellular dopamine overflow. Once three stable responses were recorded, increasing concentrations of cocaine (0.3, 1, 3, 10, 30 μM) were cumulatively applied to the bath. Once 3 stable responses were recorded at a given cocaine concentration, the next concentration was applied.
Analysis of the kinetics of fast-scan cyclic voltammetry data
Dopamine reuptake was modelled from the rate of recovery of the dopamine signal using Michaelis-Menten kinetics (85) . First, nonlinear least-square optimization was applied to fit a three-parameter exponential function with baseline shift to the reuptake phase of the dopamine response. The time constant t (tau) of the exponential corresponds to the half-life divided by log (2) , while avoiding overfitting. The parameters [DA] and app. Km were extracted from each recording. In cocaine-free conditions, signals were of relatively low amplitude, such that signal-to-noise ratio was often suboptimal for accurate parameter identification. As such, we computed kinetic parameters as percentages relative to 0.3 μM cocaine. Note that in Calipari et al (2013), app. Km at 0.3 μM cocaine was only < 10-20% greater than control levels (see their Figure 3C ), which remains small compared to the increases evoked by higher cocaine concentrations (> 1000%).
Statistical analyses
Two-way repeated measures (RM) ANOVAs (Group x Session/Time in min/Dose, Session and Dose as within-subjects variables) were used to analyze cocaine intake and locomotor activity over IntAsessions, and cocaine intake over PR sessions. Three-way RM ANOVAs (Group x Session x Time in min; Session and Time as within-subjects variables) were used to analyse locomotor activity within IntAsessions. When comparing COC to COC + A rats, 'Session', 'Time in min' and 'Dose' were analyzed as within-subjects variables and Group as a betweensubjects variable. Two-way RM ANOVA was used to analyze lever-presses during extinction, prereinstatement (Group x Session; the latter as a withinsubjects variable) and reinstatement sessions (Group x Cocaine dose, the latter as a within-subjects variable). When comparing responding before and with D-amphetamine treatment in the same rats, oneway RM ANOVA was used to analyze cocaine intake and locomotor activity over the 28 IntA-sessions. Locomotor activity averaged over the 5-min cocaine periods was analyzed before and with Damphetamine treatment using paired t-tests (IntAsession 1 versus 14 and IntA-session 15 versus 28). Two-way RM ANOVA (Group x Dose, both as withinsubjects variables) was used to compare responding under PR before and after D-amphetamine. Finally, two-way RM ANOVA was used to analyze group differences in dopamine overflow and apparent Km as a function of cocaine concentration (0.3 to 30 μM; Group x Cocaine concentration; the latter as a withinsubjects variable).
SUPPLEMENTAL FIGURES
Figure S1. Responding for cocaine under a progressive ratio schedule of reinforcement in COC rats used in Experiment 1.
In Experiment 1, after being tested for responding for cocaine (0.063-0.25 mg/kg/infusion) under a progressive ratio schedule of reinforcement, the 22 COC rats were divided into two groups. One group was then tested for extinction and cocaine-induced reinstatement of cocaine-seeking behavior. The other group was given additional IntA-sessions to self-administer cocaine, but now with D-amphetamine treatment. The figure shows that motivation to take cocaine was comparable in the two groups before this division (Dose effect, F2, 40 = 36.23, p < 0.0001; Group effect, F1, 20 = 0.001, p = 0.97; Dose x Group effect, F2, 40 = 0.06, p = 0.94). Data are mean ± SEM. n = 11/group. IntA, Intermittent Access. COC, Cocaine. A, D-amphetamine Figure S2 . D-amphetamine maintenance did not significantly change total cocaine over the 14 intermittent-access selfadministration sessions. D-amphetamine increased interindividual variability in cocaine intake, but average COC intake was equivalent with or without D-amphetamine maintenance (t11 = 0.55, p = 0.59). D-amphetamine maintenance increased the number of self-administered saline injections (t8 = 2.77, *p = 0.02, SAL versus SAL + A). IntA, Intermittent Access. COC, Cocaine. SAL, Saline. A, D-amphetamine.
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